View allAll Photos Tagged ClinicalStudies
Laboratory pathologist pipetting a patient blood sample for testing and diagnosis of disease, illness, infection, allergy or other medical condition
In 2015, Hospital Epidemiologist Dr. Tara Palmore ‘dons’ personal protective equipment (PPE) in the Special Clinical Studies Unit (SCSU). The SCSU is an inpatient unit designed with state-of-the-art infrastructure that allows for isolation capabilities and infection control while patients participate in clinical research studies.
Photo Credit: Hilary Schwab
The anti-cancer drug pembrolizumab has shown promise in slowing or stopping the progression of progressive multifocal leukoencephalopathy (PML), a typically fatal infection of the brain caused by the JC virus (JCV). This finding comes from a small-scale study by scientists at National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.
Read more: www.nih.gov/news-events/news-releases/releasing-immune-sy...
Credit: Daniel S. Reich, National Institute of Neurological Disorders and Stroke, NIH
In the Special Clinical Studies Unit (SCSU) at the NIH Clinical Center a nurse walks into a patient room. A few items of Personal Protective Equipment (PPE) are also shown on a cart outside the patient room.
The Special Clinical Studies Unit (SCSU) is an inpatient unit at the NIH Clinical Center in Bethesda, MD., designed with state-of-the-art infrastructure that allows for isolation capabilities and infection control while patients participate in clinical research studies. The unit has been in use since the summer of 2010.
Credit: National Institutes of Health
An infographic designed to clarify the different kinds of clinical studies researchers use, to explain why researchers might use them, and to touch briefly on each type’s strengths and weaknesses.
More information: www.nih.gov/institutes-nih/nih-office-director/office-com...
Credit: National Institutes of Health
Hanna Kim, M.D., M.S., is a Lawrence Shulman scholar in the NIAMS Pediatric Translational Research Branch. Her research seeks to ascertain the pathogenesis (the biological mechanisms leading to a disease) for juvenile dermatomyositis, an inflammatory muscle disease. The results of these studies may lead to new biomarkers and potential treatments for the disease. In this photo, she is examining a pediatric patient in the NIH Clinical Center.
Photographer: Richard Clark, NIAMS Office of Science Policy, Planning and Communications
Dr. Denise Ney, a researcher in nutritional sciences, follows over 160 patients with phenylketonuria (PKU). PKU is a genetic disorder caused by deficiency of an enzyme that converts the essential amino acid phenylalanine to tyrosine. To prevent brain damage and cognitive impairment those with PKU must follow a lifelong, low-phenylalanine diet through restriction of their diet and the use of a bitter tasting amino acid formula. Dr. Ney provides education on the importance of nutritional management of PKU, and under the auspices of the Orphan Grants program is conducting clinical studies to establish the acceptability and safety of unique foods made with whey protein for PKU.
For more information visit www.fda.gov/orphan.
View Nariman's recent presentation on TSI SlideShare at www.slideshare.net/CTSIatUCSF/ucsf-participant-recruitmen...
Learn more about the UCSF-CTSI Participant Recruitment Service at ctsi.ucsf.edu/our-work/participant-recruitment-service
Photo by Cindy Chew
The final of four protocol ammendments removed restrictions to permit recruitment advertising to high prevalence TBI patients; driving accidents, sports injuries and others.
Event for professionals of the pharmaceutical industry in latin america. This formus is focused on biosimilars
Event for professionals of the pharmaceutical industry in latin america. This formus is focused on biosimilars
Event for professionals of the pharmaceutical industry in latin america. This formus is focused on biosimilars
Event for professionals of the pharmaceutical industry in latin america. This formus is focused on biosimilars
We at Veeda are committed to improving the quality and accuracy of trials by simplifying the process. With our vast experience in managing complex projects with great finesse and accuracy, we can design trials that give the right answers, in the most simple and unobtrusive way for patients and are acceptable to regulators and sponsors.
To assist you with your clinical trials requirements, write to us at info@veedacr.com or visit www.veedacr.com/services/clinical-trials/
Event for professionals of the pharmaceutical industry in latin america. This formus is focused on biosimilars
Keystone Heart’s TriGUARD 3™ is designed to provide full coverage of all three major aortic vessels to minimize the risk of cerebral damage during TAVR. www.keystoneheart.com/
At Veeda, we place a firm emphasis on following our value system to deliver quality without compromising on safety while upholding ethics, good clinical practices, and regulatory compliance. Our values and commitment to quality and perfection have helped us to establish ourselves as a partner of choice for our Sponsors and our Stakeholders.
For business inquiries, write to us at info@veedacr.com or visit www.veedacr.com
We are one of the leading CROs in India, delivering a range of extensive clinical research services for BA BE studies, Inhalation, Suppository, Glucose Clamp, clinical trials and more.
For business inquiries, write to us at info@veedacr.com
Get access to 150 unique GCP findings from www.gcpfinding.com/gcp-finding/
These findings will help: Clinical Research Associate – Ensuring GCP findings are captured during site monitoring visit
Clinical Trial Coordinator - To avoid GCP findings while completing study documents
Clinical Investigator- Keeping investigative site compliant with GCP requirements
Contact us for more details
GCP Finding | Clinical Research
LinkedIn: www.linkedin.com/company/66181788
Website: www.gcpfinding.com
Facebook: www.facebook.com/GCP-Finding-109859400786697
Email: info@gcpfinding.com
The training contains presentations that will allow participant to enjoy the learning process and easily understand the fundamentals of Good Clinical Practice. Also read ICH GCP E6 (R2) guideline contents through speaker notes.
Get your free web based certification on completion of training sessions and quiz.
Contact us for more details
GCP Finding | Clinical Research
LinkedIn: www.linkedin.com/company/66181788
Website: www.gcpfinding.com
Facebook: www.facebook.com/GCP-Finding-109859400786697
Email: info@gcpfinding.com
The Center’s main objective is to always have its patient’s best interests at heart. The sole reason as to why it is working hard to ensure that they have the right information for cancer treatment. Many clinics have sprung up purporting to treat cancer using the exact remedy as the Budwig Center Germany.
Get access to 150 unique GCP findings from www.gcpfinding.com/gcp-finding/
These findings will help:
Project Manager-Training team members on unique findings and ensuring compliance
CRA/QA Auditor – Ensuring GCP findings are captured during site visit
Study Investigator- Keeping investigative site compliant with GCP requirements
Registered Nurse/CRC- To avoid such GCP findings while completing study documents
Get access to 150 unique GCP findings from www.gcpfinding.com/gcp-finding/
These findings will help: Clinical Research Associate – Ensuring GCP findings are captured during site monitoring visit
Clinical Trial Coordinator - To avoid GCP findings while completing study documents
Clinical Investigator- Keeping investigative site compliant with GCP requirements
Contact us for more details
GCP Finding | Clinical Research
LinkedIn: www.linkedin.com/company/66181788
Website: www.gcpfinding.com
Facebook: www.facebook.com/GCP-Finding-109859400786697
Email: info@gcpfinding.com
Authors: Gülşen Uz, Tuğba Pesen, Ahsen Berber, Cenk Kığ, Bedia Palabıyık, Ayşegül Topal Sarıkaya
Abstract: Magnesium is vital for many biological processes such as energy metabolism, nucleic acid, and protein synthesis, signal transduction, and cell division. Impairment of magnesium homeostasis is associated with many diseases, especially cardiovascular diseases, hypertension, type 2 diabetes, and cancer. More than 300 million people worldwide struggle with type 2 diabetes, and this number is growing exponentially. Clinical studies have shown that serum magnesium levels were decreased in patients with type 2 diabetes and that magnesium supplementation has positive effects on glucose metabolism. In this study, glucose consumption and the expression levels of glucose transporters (ght1, ght2, ght5) were investigated in magnesium transportrestricted mutant strain of Schizosaccharomyces pombe yeast, which is similar to mammalian cells in terms of biological processes and genetic mechanisms. In mutant strain with limited magnesium transport, glucose consumption increased due to the increase in magnesium added to the medium. The expression level of ght1, ght2, one of the glucose transporters, increased in 30 mM Mg2+ supplemented medium, decreased at higher magnesium concentration (75 mM), where optimum growth was observed for the strain, and there was no significant change in the expression level of ght5. Our findings indicate that the glucose transporters ght1 and ght2 are regulated by a different mechanism than ght5.
Keywords: magnesium deficiency, glucose transport, S. pombe
This module is crafted for those who are involved in conducting clinical trials, at sponsor or CRO or at the Investigator site. There are nearly 1300 pages containing:
Clinical Investigator/Sponsor Investigator
– 220 FDA Warning Letters
Institutional Review Board
– 73 FDA Warning Letters
Sponsor/Monitor/Contract Research Organization
– 53 FDA Warning Letters
For Demo
www.gcpfinding.com/fda-warning-letters-demo/
Contact us for more details
GCP Finding | Clinical Research
LinkedIn: www.linkedin.com/company/66181788
Website: www.gcpfinding.com
Facebook: www.facebook.com/GCP-Finding-109859400786697
Email: info@gcpfinding.com